DE602005022759D1 - Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus - Google Patents

Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Info

Publication number
DE602005022759D1
DE602005022759D1 DE602005022759T DE602005022759T DE602005022759D1 DE 602005022759 D1 DE602005022759 D1 DE 602005022759D1 DE 602005022759 T DE602005022759 T DE 602005022759T DE 602005022759 T DE602005022759 T DE 602005022759T DE 602005022759 D1 DE602005022759 D1 DE 602005022759D1
Authority
DE
Germany
Prior art keywords
various types
papilloma virus
acid detection
human papilloma
acidic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022759T
Other languages
English (en)
Inventor
Neeraj Rao
Sylvia A Norman
Jennifer J Bungo
William L Hanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of DE602005022759D1 publication Critical patent/DE602005022759D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
DE602005022759T 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus Active DE602005022759D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63445804P 2004-12-08 2004-12-08
PCT/US2005/044291 WO2006063065A2 (en) 2004-12-08 2005-12-08 Detection of nucleic acids from multiple types of human papillomaviruses

Publications (1)

Publication Number Publication Date
DE602005022759D1 true DE602005022759D1 (de) 2010-09-16

Family

ID=36578528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022759T Active DE602005022759D1 (de) 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Country Status (8)

Country Link
US (19) US7354719B2 (de)
EP (1) EP1819835B1 (de)
JP (9) JP5020825B2 (de)
AT (1) ATE476528T1 (de)
AU (3) AU2005314061B2 (de)
CA (1) CA2588581C (de)
DE (1) DE602005022759D1 (de)
WO (1) WO2006063065A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000500342A (ja) * 1995-11-15 2000-01-18 ジェン−プローブ・インコーポレーテッド ヒトパピローマウイルス核酸に相補的な核酸プローブおよび関連する方法およびキット
DE602005022759D1 (de) 2004-12-08 2010-09-16 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
EP1997914A1 (de) * 2007-06-01 2008-12-03 Università Degli Studi Di Milano - Bicocca Identifizierung und Quantifizierung onkogener HPV-Nukleinsäuren mittels PCR-Assays in Echtzeit
EP2218780B1 (de) * 2007-10-19 2013-07-24 Eiken Kagaku Kabushiki Kaisha Nukleinsäureamplifikationsverfahren sowie reagens und reagenskit zur verwendung bei dem verfahren
PT2209920T (pt) * 2007-11-01 2016-08-02 Self-Screen B V Método inovador de deteção para hpvs cervicais
CN102209793B (zh) 2008-11-19 2014-09-03 达雅高生物科技有限公司 用于检测hpv的核苷酸序列、方法和试剂盒
US8921039B2 (en) 2009-02-26 2014-12-30 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
EP2427763A4 (de) 2009-05-07 2013-08-21 Oncohealth Corp Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen
JP5819851B2 (ja) 2010-01-08 2015-11-24 オンコヘルス コーポレーション Ｈｐｖ関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力ｈｐｖ免疫アッセイ
US9410189B2 (en) * 2010-04-30 2016-08-09 Co-Diagnostics, Inc. Methods of preventing non-specific reactions of nucleotide sequences
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ
EP2455658B1 (de) 2010-11-17 2016-03-02 Orcan Energy AG Verfahren und Vorrichtung zur Verdampfung organischer Arbeitsmedien
AU2013205122B2 (en) * 2012-10-11 2016-11-10 Gen-Probe Incorporated Compositions and Methods for Detecting Human Papillomavirus Nucleic Acid
CN103409560A (zh) * 2013-08-19 2013-11-27 潘晓静 一种广谱、高效、经济的高危人乳头状瘤病毒的pcr检测方法
CN108350448A (zh) * 2015-09-10 2018-07-31 株式会社钟化 从含有核酸的样品中分离核酸的方法及用于该方法的装置
US11377688B2 (en) 2017-11-17 2022-07-05 Gen-Probe Incorporated Compositions and methods for detecting C1orf43 nucleic acid
EP4067471A1 (de) 2019-11-26 2022-10-05 Yokogawa Electric Corporation Spitzenvorrichtung, spitzenbehältersatz, spitzenelektrodenvorrichtung und spitzenelektrodensatz
JP2023518032A (ja) * 2020-03-16 2023-04-27 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 腫瘍誘導性ウイルスｄｎａの選択的検出のための組成物及び方法
CN114020363B (zh) * 2021-11-15 2023-12-15 海能达通信股份有限公司 群组附着方法及相应设备

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876922A (en) * 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
ES2039254T3 (es) 1986-03-21 1995-04-01 Pasteur Institut Secuencias determinadas de adn, derivadas de un genoma de papilomavirus, sus usos con finalidades de diagnostico in vitro y la produccion de composiciones antigenas.
US5783412A (en) * 1987-02-26 1998-07-21 Biosearch International Pty. Ltd. Method of detection of carcinogenic human papillomavirus
US4849332A (en) * 1987-05-26 1989-07-18 Life Technologies, Inc. Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
US4908306A (en) * 1987-06-12 1990-03-13 Life Technologies, Inc. Human papillomavirus 56 nucleic acid hybridization probes and methods for employing the same
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
EP0338067A4 (en) * 1987-10-02 1991-05-02 Microprobe Corporation Human papillomavirus type diagnosis with nucleotide probes
US5030557A (en) * 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
FR2627590A1 (fr) 1988-02-24 1989-08-25 Ire Celltarg Sa Sonde d'acides nucleiques comportant un nucleotide terminal modifie chimiquement en 5(prime) (oh) en vue de son marquage non radioactif et procedes de preparation
FR2632956B2 (fr) * 1988-05-13 1991-07-12 Pasteur Institut Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) * 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
JPH05501650A (ja) 1989-12-01 1993-04-02 バイシス・インコーポレーテツド Ｈｐｖ転写物の検出
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
JP2785164B2 (ja) 1990-08-20 1998-08-13 寳酒造株式会社 ヒトパピローマウイルスの検出方法
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
FR2678284B1 (fr) * 1991-06-28 1993-10-08 Pasteur Institut Sequences d'adn derivees du genome du papillomavirus hpv42, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus et a la production de compositions immunogenes.
ZA929351B (en) * 1991-12-11 1993-06-04 Igen Inc Electrochemiluminescent label for DNA assays.
EP1288296A3 (de) 1992-05-11 2003-03-12 Ribozyme Pharmaceuticals, Inc. Verfahren und Reagenz zur Hemmung der HBV viralen Replikation
ZA936016B (en) * 1992-08-24 1994-03-10 Akzo Nv Method for nucleic acid amplification
US5618536A (en) 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
EP0655091A1 (de) 1993-05-06 1995-05-31 Baxter Diagnostics Inc. Nachweismethode des menschlichen papillomavirus
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
AUPM566794A0 (en) * 1994-05-17 1994-06-09 University Of Queensland, The Process and product
WO1996009375A1 (en) * 1994-09-22 1996-03-28 Merck & Co., Inc. Dna encoding human papillomavirus type 6a
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
DE19506561C1 (de) * 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
IL117591A0 (en) * 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein
JP2000500342A (ja) * 1995-11-15 2000-01-18 ジェン−プローブ・インコーポレーテッド ヒトパピローマウイルス核酸に相補的な核酸プローブおよび関連する方法およびキット
US5981173A (en) 1996-02-14 1999-11-09 Institut Pasteur Genital human papillomavirus type 68a (HPV-68a), related to the potentially oncogenic HPV-39
AU2672597A (en) * 1996-04-15 1997-11-07 University Of New Mexico Probes for the detection of human papillomavirus
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
CA2313483C (en) * 1997-12-12 2017-12-05 Digene Corporation Assessment of human papilloma virus-related disease
US7494658B2 (en) * 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
AU766403C (en) * 1998-09-04 2004-05-27 Aventis Pasteur Limited Treatment of cervical cancer
US6313373B1 (en) * 1998-10-30 2001-11-06 Case Western Reserve University Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
EP1006199A1 (de) * 1998-12-03 2000-06-07 Kreatech Biotechnology B.V. Verfahren zur Herstellung von Verknüpfungen an ausgewählten Positionen von Nukleinsäuresträngen und deren Verwendung
SE515668C2 (sv) 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
ATE456677T1 (de) * 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
EP1222289B1 (de) * 1999-10-20 2008-04-16 The Johns Hopkins University School Of Medicine Chimäre immunogene zusammensetzungen und dafür kodierende nukleinsäure
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
WO2001042467A2 (en) 1999-12-08 2001-06-14 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
DE10009143B4 (de) * 2000-02-26 2012-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum Nachweis von Humanen Papillomviren
US6936443B2 (en) * 2000-04-03 2005-08-30 Cytyc Corporation Detection and typing of human papillomavirus using PNA probes
JP2001321168A (ja) 2000-05-12 2001-11-20 Toshiyuki Sasagawa Ｈｐｖ感染型の同定方法
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
GB0018050D0 (en) * 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
DE10059630A1 (de) * 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
AU3090102A (en) * 2000-12-14 2002-06-24 Gen Probe Inc Method and kit for enhancing the association rates of polynucleotides
EP1409730A2 (de) * 2001-06-14 2004-04-21 University of Wales College of Medicine Nachweismethode für viren umfassend primer und kit
WO2003014402A2 (en) * 2001-08-08 2003-02-20 Glaxosmithkline Biologicals S.A. Method for identification of type specific polynucleotide sequences
US6884605B2 (en) * 2001-08-09 2005-04-26 Board Of Trustees Of The University Of Arkansas Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
GB0120938D0 (en) 2001-08-29 2001-10-17 Norchip As Detection of human papillomavirus E7 mRNA
GB0200258D0 (en) * 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
US7553623B2 (en) * 2002-01-07 2009-06-30 Norchip A/S Method for detecting human papillomavirus mRNA
AU2003270823A1 (en) * 2002-09-19 2004-04-08 Johns Hopkins University School Of Medicine Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
SE0202897D0 (sv) * 2002-10-01 2002-10-01 Quantovir Ab Method and kit for quantitative and qualitative determination of human papillomavirus
NZ556544A (en) 2002-10-03 2008-11-28 Wyeth Corp Human papillomavirus polypeptides and immunogenic compositions
EP1664348B8 (de) * 2003-09-25 2019-06-12 Third Wave Technologies, Inc. Hpv-nachweis
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
EP1778867B1 (de) 2004-07-01 2010-04-28 Gen-Probe Incorporated Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
DE602005022759D1 (de) * 2004-12-08 2010-09-16 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
US20060134615A1 (en) * 2004-12-20 2006-06-22 James Linder Method for the simultaneous detection of HPV RNA and DNA in a sample
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof
US20070111960A1 (en) * 2005-03-04 2007-05-17 Advandx, Inc. High affinity probes for analysis of human papillomavirus expression
JP6076679B2 (ja) * 2012-10-15 2017-02-08 ナカ工業株式会社 手摺笠木

Also Published As

Publication number Publication date
US20150292047A1 (en) 2015-10-15
JP6038067B2 (ja) 2016-12-07
EP1819835A2 (de) 2007-08-22
US11613788B2 (en) 2023-03-28
US20130078618A1 (en) 2013-03-28
AU2010201656A1 (en) 2010-05-20
JP5648016B2 (ja) 2015-01-07
JP6590857B2 (ja) 2019-10-16
US20200165689A1 (en) 2020-05-28
JP2019213560A (ja) 2019-12-19
US8574841B2 (en) 2013-11-05
US8026066B2 (en) 2011-09-27
US20180002768A1 (en) 2018-01-04
AU2005314061B2 (en) 2010-01-28
JP2023083425A (ja) 2023-06-15
US20150292046A1 (en) 2015-10-15
AU2012203392A1 (en) 2012-06-28
US11359252B2 (en) 2022-06-14
US20190376152A1 (en) 2019-12-12
US10465255B2 (en) 2019-11-05
US20140030701A1 (en) 2014-01-30
ATE476528T1 (de) 2010-08-15
US11624096B2 (en) 2023-04-11
CA2588581A1 (en) 2006-06-15
US20060121516A1 (en) 2006-06-08
US7682792B2 (en) 2010-03-23
JP2021176306A (ja) 2021-11-11
US9074263B2 (en) 2015-07-07
US20140024021A1 (en) 2014-01-23
US20190002995A1 (en) 2019-01-03
EP1819835B1 (de) 2010-08-04
US10047407B2 (en) 2018-08-14
US20200032355A1 (en) 2020-01-30
JP2018138061A (ja) 2018-09-06
AU2005314061A1 (en) 2006-06-15
US20210010095A1 (en) 2021-01-14
CA2588581C (en) 2011-05-31
US8334098B2 (en) 2012-12-18
JP2016025875A (ja) 2016-02-12
US8835114B2 (en) 2014-09-16
US20150094235A1 (en) 2015-04-02
US10968494B2 (en) 2021-04-06
US20210164063A1 (en) 2021-06-03
JP2008522620A (ja) 2008-07-03
JP5020825B2 (ja) 2012-09-05
US10640836B2 (en) 2020-05-05
US8828660B2 (en) 2014-09-09
US7354719B2 (en) 2008-04-08
US20100105027A1 (en) 2010-04-29
JP2014138615A (ja) 2014-07-31
US20140038173A1 (en) 2014-02-06
WO2006063065A2 (en) 2006-06-15
EP1819835A4 (de) 2009-09-02
JP6857632B2 (ja) 2021-04-14
JP6128705B2 (ja) 2017-05-17
US20080311559A1 (en) 2008-12-18
US9765407B2 (en) 2017-09-19
AU2010201656B2 (en) 2012-03-15
US20110311961A1 (en) 2011-12-22
WO2006063065A3 (en) 2008-07-31
US20140342351A1 (en) 2014-11-20
JP2012165751A (ja) 2012-09-06
US8785125B2 (en) 2014-07-22
AU2012203392B2 (en) 2013-09-12
US10711317B2 (en) 2020-07-14
US9328392B2 (en) 2016-05-03
JP2017113038A (ja) 2017-06-29

Similar Documents

Publication Publication Date Title
DE602005022759D1 (de) Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
Fozouni et al. Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy
EP2471805A3 (de) Zusammensetzungen und Verfahren zur spezifischen Detektion von Nukleinsäuren der Viren Influenza A oder B
MX2012002411A (es) Metodos de ensayo para el mdv-1.
Fozouni et al. Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone
WO2004053105A3 (en) Direct SNP detection with unamplified DNA
WO2007021250A3 (en) Method and/or apparatus of oligonucleotide design and/or nucleic acid detection
WO2007066831A3 (en) Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier
WO2010083250A3 (en) Single-cell nucleic acid analysis
MX2012001000A (es) Metodo y kit para la deteccion de un microorganismo.
EA201101141A1 (ru) Получение закрытой линейной днк
EP2412830A3 (de) Zusammensetzungen und Verfahren zur Detektion von Hepatitis-A-Virus-Nukleinsäure
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
NZ601652A (en) Set of probes for the detection and typing of 46 human papillomavirus mucosal types
WO2006131892A3 (en) Amplification of nucleic acids with magnetic detection
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
ATE456668T1 (de) Nachweis und typisierung des papillomavirus mittels pna-sonden
EP1988178A3 (de) Nukleotid-Primer-Set und Nukleotidsonde für den Nachweis des Serum-Amyloid A1 (SAA1)-Genotyps
EA200601559A1 (ru) Детектирование вируса папилломы человека
ATE557098T1 (de) Nachweis hochgradiger dysplasie in zervixzellen
RU2014122607A (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
Geraldi et al. Synthetic biology-based portable in vitro diagnostic platforms
DE602005023002D1 (de) Hybridisierungsverfahren
WO2010099378A3 (en) Assay for detection of human parvovirus nucleic acid
Lace et al. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration